<DOC>
	<DOC>NCT03066895</DOC>
	<brief_summary>This is a pilot, randomized, safety and efficacy study of an investigational device (i.e. BabyGentleStickâ„¢; BGS, Actuated Medical, Inc). The primary study objectives are to obtain subject feedback, assess device performance; and ascertain potential harm in healthy adult volunteers.</brief_summary>
	<brief_title>BGS Neonatal Pilot Study</brief_title>
	<detailed_description />
	<criteria>Medically stable late preterm/term neonates with a gestational age at birth of &gt; 35 weeks gestation at birth Sex: male or female Congenital anomalies or conditions at birth impacting central nervous system functioning and autonomic measurements Known risk for bleeding (i.e. Hemophilia, blood clotting or protein disorders) Prolonged labor or delayed birth with evidence of perinatal depression (e.g. Infant Apgar scores below 5) Identified maternal opiate dependency during pregnancy placing the infant at risk for opiate withdrawal, also known as neonatal abstinence syndrome (NAS) Critical illness in the mother preventing the ability to obtain informed consent from parents</criteria>
	<gender>All</gender>
	<minimum_age>35 Weeks</minimum_age>
	<maximum_age>42 Weeks</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>